Preeclampsia resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Synonyms and keywords:
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Causes
Common Causes
Common cause of preeclampsia include uteroplacental ischemia and genetic predisposition due to the following:[1][2]
- The formation of atheromatous plaques and fibrinoid necrosis of the spiral vessel walls
- Oxidative stress in trophoblast cells
- Apoptosis in trophoblast cells
- Systemic inflammatory response
- Vasospasm
- Platelet aggregation
- Thrombin formation
- Deposition of the fibrin in multiple organs
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Gestational Hypertension.
Pregnant woman with history of Hypertension | |||||||||||||||||||||||||||||||||||||||||||||||
Take complete history | |||||||||||||||||||||||||||||||||||||||||||||||
Ask about previous obstetric history if she was previous pregnant : ❑ Ask about previous pregnancies including miscarriages and terminations. ❑ Length of gestation. ❑ Ask about mode of delivery. ❑ Ask if there was similar complaints during previous pregnancy? ❑ Was there any complications throughout the pregnancy or during delivery such as shoulder dystocia, postpartum haemorrhage ? | |||||||||||||||||||||||||||||||||||||||||||||||
Ask the following questions about menstrual history : ❑ Age of menarche ❑ Last menstrual period ❑ Is the menstrual flow normal? How many pads she has to use in a day? ❑ Is there any foul smell or colour change? ❑ How many days does the menstruation stay? ❑ Contraceptive history for example oral contraceptives, intrauterine device | |||||||||||||||||||||||||||||||||||||||||||||||
See if following factors are present: ❑ History of hypertension | |||||||||||||||||||||||||||||||||||||||||||||||
Ask about associated symptoms OF preeclampsia: ❑ Severe headaches | |||||||||||||||||||||||||||||||||||||||||||||||
PRE-ECLAMPSIA[3] ❑ Blood pressure higher than 140/90 measured on two separate occasions, more than 6 hours apart.[3] | |||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of mild hypertension and preeclampsia.
Woman with mild hypertension and pre eclampsia | |||||||||||||||||||||||||||||||||||||||||
Evaluate maternal and fetal condition | |||||||||||||||||||||||||||||||||||||||||
❑ ≥ 37 weeks of gestation, Bishop score ≥ 6, non-complaint patient ❑ ≥34 weeks gestation, Labor or rupture of membranes, Abnormal fetal testing, Intrauterine growth restriction | Yes | Delivery | |||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||
<37 weeks | 37-39 weeks | ||||||||||||||||||||||||||||||||||||||||
Shown below is an algorithm summarizing the treatment of severe preeclampsia.
Woman with severe pre eclampsia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Evaluate maternal and fetal condition for 24 hours. ❑ Administer Magnesium sulphate X 24 hours. ❑ Anti-hypertensives if systolic blood pressure ≥ 160mm Hg, Diastolic ≥110 mmHg and meant retrial blood pressure ≥125 mmHg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check if following are present: --- ❑ Maternal distress❑ Non-reassuring fetal status. ❑ Labor or rupture of membranes. ❑ >34 weeks of gestation. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Severe intrauterine growth restriction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
← | Steroids | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
← | 33-34 weeks of gestation | 23-32 weeks of gestation | <23 weeks of gestation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Anti-hypertensives if required. ❑ Daily maternal and fetal evaluation. ❑ Delivery at 34 weeks. | termination of pregnancy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.
References
- ↑ Lye, P.; Bloise, E.; Dunk, C.; Javam, M.; Gibb, W.; Lye, S.J.; Matthews, S.G. (2013). "Effect of oxygen on multidrug resistance in the first trimester human placenta". Placenta. 34 (9): 817–823. doi:10.1016/j.placenta.2013.05.010. ISSN 0143-4004.
- ↑ Mayrink, J.; Costa, M. L.; Cecatti, J. G. (2018). "Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction". The Scientific World Journal. 2018: 1–9. doi:10.1155/2018/6268276. ISSN 2356-6140.
- ↑ 3.0 3.1 3.2 Lo JO, Mission JF, Caughey AB (April 2013). "Hypertensive disease of pregnancy and maternal mortality". Curr Opin Obstet Gynecol. 25 (2): 124–32. doi:10.1097/GCO.0b013e32835e0ef5. PMID 23403779.